|
PRKAR2A expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.464800E-01 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.611600E-01 |
| Normal-vs-AfricanAmerican |
2.349000E-01 |
| Normal-vs-Asian |
2.863800E-01 |
| Caucasian-vs-AfricanAmerican |
9.744000E-01 |
| Caucasian-vs-Asian |
3.954200E-01 |
| AfricanAmerican-vs-Asian |
4.316600E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.915800E-01 |
| Normal-vs-Female |
2.241400E-01 |
| Male-vs-Female |
5.627800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.329400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.917450E-01 |
| Normal-vs-Age(61-80Yrs) |
2.337000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.143000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.163000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.649400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.092000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.414800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.182400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.109960E-02 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
5.107800E-01 |
| Normal-vs-Pheochromocytoma |
2.342600E-01 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
1.737810E-01 |
| Paraganglioma-vs-Pheochromocytoma |
3.993800E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.586600E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
3.565200E-01 |
|
|
